相关实验视频
Updated: Mar 2, 2026

09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
22.4K
植物性饮食模式与认知障碍和痴呆症风险之间的关联:系统性审查和剂量反应元分析
Jui-Hsiu Tsai1, Tou-Yuan Tsai2, Hua Li3
1Department of Psychiatry, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan; School of Medicine, Tzu Chi University, Hualien, Taiwan.
The journal of prevention of Alzheimer's disease
|February 28, 2026
概括
坚持植物性饮食,特别是富含健康食品的饮食,可能会降低痴呆症的风险. 然而,不健康的植物性食物可能会增加风险,因此需要进一步研究以得出关于植物性饮食和认知健康的最终结论.
科学领域:
- 营养科学 营养科学
- 神经学 神经学
- 流行病学 流行病学
背景情况:
- 关于植物性饮食能预防认知障碍和痴呆症的证据尚不确定.
- 某些植物性食物,如精制碳水化合物和反式脂肪,可能会增加痴呆风险.
研究的目的:
- 量化合成关于植物性饮食和认知障碍和痴呆症风险的前性队列研究.
- 评估坚持植物性饮食和认知能力下降之间的关联.
主要方法:
- 7项前性队列研究 (221,380名参与者) 的系统审查和元分析.
- 使用总体植物性饮食指数 (PDI),健康植物性饮食指数 (hPDI) 和不健康植物性饮食指数 (uPDI) 评估饮食模式.
- 随机效应模型用于计算聚合风险比率;采用剂量反应元分析.
主要成果:
- 更多地坚持植物性饮食与显著降低认知障碍和痴呆的风险有关 (综合风险比:0.74).
- 总体而言,PDI和hPDI显示了与认知风险的负面关联.
- uPDI与认知障碍和痴呆症风险增加有显著的积极关联.
结论:
- 富含健康食品的植物性饮食可能与降低认知障碍和痴呆症风险有关.
- 不健康的植物性饮食模式可能会增加这些风险.
- 由于研究的局限性,需要进一步的随机对照试验来确定因果关系.
相关概念视频
Dementia
615
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
615
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Cancer Prevention
8.4K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
8.4K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
738
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
738
Psychoneuroimmunology: Diabetes and Cancer
547
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
547
Pharmacodynamics in Geriatric Patients: Effects of Age
287
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
287

